Angelika Fath-Goodin, Ph.D.

Angelika Fath-Goodin, PhD
Chief Executive Officer (CEO), Co-Founder ParaTechs, Kentucky (IDeA State)

Angelika’s Success Story

Contribution to Science

The Non-Surgical Embryo Transfer (NSET) device revolutionizes embryo transfer in mice making it ideal for producing transgenic, knock-out or knock-in mice without surgery. NSET is as effective as current surgical procedures.

  • Angelika loves being the CEO of a small company because it “means you’re always wearing different hats and almost every day you’re faced with a new challenge to overcome.”
  • Angelika feels very fortunate to have achieved a remarkable level of grant award success.
  • Nineteen SBIR/STTR Phase I applications submitted - twelve awards - a 63% success rate.
  • Seven Phase II SBIR/STTR applications submitted - 4 awards - a 67% success rate.
  • Angelika’s award significance: “The receipt of our ORIP grant marked a turning point for us and supported our move from our lab of 600 sq. ft. in small business incubator space at the University of Kentucky to 4000 sq. ft. of newly renovated laboratory space.”

NIH-ORIP does not endorse the product or the company named above. This material is for informational purposes only.

NIH-ORIP does not endorse the product or the company named above. This material is for informational purposes only.